Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma

Kenichi Saigo, Kenichi Yoshida, Ryuji Ikeda, Yoshiko Sakamoto, Yoshiki Murakami, Tetsuro Urashima, Takehide Asano, Takashi Kenmochi, Ituro Inoue

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Integration of hepatitis B virus (HBV) DNA into host DNA is detected in about 90% of HBV-related hepatocellular carcinoma (HCC), but the preferential sites of the viral integration etiologically relevant to oncogenesis have been controversial. By using an adaptor-ligation/suppression-PCR, we identified four integrations into the myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4) gene from 10 HCC patients with positive HBV surface antigen (HBsAg). Determination of the cellular-virus DNA junction demonstrated that various lengths of the virus were integrated within 300 bp of intron 3 flanked by the Alu element of MLL4. Chimeric hepatitis B virus X gene (HBx)/MLL4 transcripts and the HBx fusion proteins were detected. DNA microarray revealed that HBx/MLL4 fusion proteins suppressed unique genes in HepG2 cells. Finally, chromosomal translocations of intron 3 of MLL4 to the specific region of chromosome 17p11.2 in 22 out of 32 HCC patients were observed, showing that the intron 3 region of MLL4 gene would be a target of translocation breakpoint. In conclusion, the present data suggest that the translocation breakpoint of MLL4 gene is one of the preferential targets for HBV DNA integration into the MLL4 gene and the HBV DNA integration may be involved in liver oncogenesis.

Original languageEnglish
Pages (from-to)703-708
Number of pages6
JournalHuman Mutation
Volume29
Issue number5
DOIs
Publication statusPublished - 01-05-2008

Fingerprint

Gene Rearrangement
Hepatitis B virus
Hepatocellular Carcinoma
Leukemia
DNA
Virus Integration
Introns
Genes
Carcinogenesis
Alu Elements
Genetic Translocation
DNA Viruses
Hep G2 Cells
Hepatitis B Surface Antigens
Oligonucleotide Array Sequence Analysis
Ligation
Proteins
Chromosomes
Viruses
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Saigo, Kenichi ; Yoshida, Kenichi ; Ikeda, Ryuji ; Sakamoto, Yoshiko ; Murakami, Yoshiki ; Urashima, Tetsuro ; Asano, Takehide ; Kenmochi, Takashi ; Inoue, Ituro. / Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. In: Human Mutation. 2008 ; Vol. 29, No. 5. pp. 703-708.
@article{13d5fffd869f4a59a93f841f96510c71,
title = "Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma",
abstract = "Integration of hepatitis B virus (HBV) DNA into host DNA is detected in about 90{\%} of HBV-related hepatocellular carcinoma (HCC), but the preferential sites of the viral integration etiologically relevant to oncogenesis have been controversial. By using an adaptor-ligation/suppression-PCR, we identified four integrations into the myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4) gene from 10 HCC patients with positive HBV surface antigen (HBsAg). Determination of the cellular-virus DNA junction demonstrated that various lengths of the virus were integrated within 300 bp of intron 3 flanked by the Alu element of MLL4. Chimeric hepatitis B virus X gene (HBx)/MLL4 transcripts and the HBx fusion proteins were detected. DNA microarray revealed that HBx/MLL4 fusion proteins suppressed unique genes in HepG2 cells. Finally, chromosomal translocations of intron 3 of MLL4 to the specific region of chromosome 17p11.2 in 22 out of 32 HCC patients were observed, showing that the intron 3 region of MLL4 gene would be a target of translocation breakpoint. In conclusion, the present data suggest that the translocation breakpoint of MLL4 gene is one of the preferential targets for HBV DNA integration into the MLL4 gene and the HBV DNA integration may be involved in liver oncogenesis.",
author = "Kenichi Saigo and Kenichi Yoshida and Ryuji Ikeda and Yoshiko Sakamoto and Yoshiki Murakami and Tetsuro Urashima and Takehide Asano and Takashi Kenmochi and Ituro Inoue",
year = "2008",
month = "5",
day = "1",
doi = "10.1002/humu.20701",
language = "English",
volume = "29",
pages = "703--708",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "5",

}

Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. / Saigo, Kenichi; Yoshida, Kenichi; Ikeda, Ryuji; Sakamoto, Yoshiko; Murakami, Yoshiki; Urashima, Tetsuro; Asano, Takehide; Kenmochi, Takashi; Inoue, Ituro.

In: Human Mutation, Vol. 29, No. 5, 01.05.2008, p. 703-708.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma

AU - Saigo, Kenichi

AU - Yoshida, Kenichi

AU - Ikeda, Ryuji

AU - Sakamoto, Yoshiko

AU - Murakami, Yoshiki

AU - Urashima, Tetsuro

AU - Asano, Takehide

AU - Kenmochi, Takashi

AU - Inoue, Ituro

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Integration of hepatitis B virus (HBV) DNA into host DNA is detected in about 90% of HBV-related hepatocellular carcinoma (HCC), but the preferential sites of the viral integration etiologically relevant to oncogenesis have been controversial. By using an adaptor-ligation/suppression-PCR, we identified four integrations into the myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4) gene from 10 HCC patients with positive HBV surface antigen (HBsAg). Determination of the cellular-virus DNA junction demonstrated that various lengths of the virus were integrated within 300 bp of intron 3 flanked by the Alu element of MLL4. Chimeric hepatitis B virus X gene (HBx)/MLL4 transcripts and the HBx fusion proteins were detected. DNA microarray revealed that HBx/MLL4 fusion proteins suppressed unique genes in HepG2 cells. Finally, chromosomal translocations of intron 3 of MLL4 to the specific region of chromosome 17p11.2 in 22 out of 32 HCC patients were observed, showing that the intron 3 region of MLL4 gene would be a target of translocation breakpoint. In conclusion, the present data suggest that the translocation breakpoint of MLL4 gene is one of the preferential targets for HBV DNA integration into the MLL4 gene and the HBV DNA integration may be involved in liver oncogenesis.

AB - Integration of hepatitis B virus (HBV) DNA into host DNA is detected in about 90% of HBV-related hepatocellular carcinoma (HCC), but the preferential sites of the viral integration etiologically relevant to oncogenesis have been controversial. By using an adaptor-ligation/suppression-PCR, we identified four integrations into the myeloid/lymphoid or mixed-lineage leukemia 4 (MLL4) gene from 10 HCC patients with positive HBV surface antigen (HBsAg). Determination of the cellular-virus DNA junction demonstrated that various lengths of the virus were integrated within 300 bp of intron 3 flanked by the Alu element of MLL4. Chimeric hepatitis B virus X gene (HBx)/MLL4 transcripts and the HBx fusion proteins were detected. DNA microarray revealed that HBx/MLL4 fusion proteins suppressed unique genes in HepG2 cells. Finally, chromosomal translocations of intron 3 of MLL4 to the specific region of chromosome 17p11.2 in 22 out of 32 HCC patients were observed, showing that the intron 3 region of MLL4 gene would be a target of translocation breakpoint. In conclusion, the present data suggest that the translocation breakpoint of MLL4 gene is one of the preferential targets for HBV DNA integration into the MLL4 gene and the HBV DNA integration may be involved in liver oncogenesis.

UR - http://www.scopus.com/inward/record.url?scp=42949100259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949100259&partnerID=8YFLogxK

U2 - 10.1002/humu.20701

DO - 10.1002/humu.20701

M3 - Article

C2 - 18320596

AN - SCOPUS:42949100259

VL - 29

SP - 703

EP - 708

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 5

ER -